Arani, L S, Zirakchian Zadeh, M, Saboury, B, Revheim, M E, Øestergaard, B, Borja, A J, Samadi Samarin, D, Mehdizadeh Seraj, S, Kalbush, E, Ayubcha, C, Morris, M A, Werner, T J, Abildgaard, N, Høilund-Carlsen, P F & Alavi, A 2021, ' Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using 18 F-sodium fluoride PET/CT ', Journal of Nuclear Cardiology, vol. 28, no. 6, pp. 3044-3054 . https://doi.org/10.1007/s12350-020-02446-0
Background: To compare the NaF uptake in the thoracic aorta and whole heart, as an early indicator of atherosclerosis, in multiple myeloma (MM) and smoldering multiple myeloma (SMM) patients with a healthy control (HC) group. Methods: Forty-four untreated myeloma patients (35 MM and nine SMM) and twenty-six age and gender-matched HC subjects were collected. Each individual’s NaF uptake in three parts of the aorta (AA: ascending aorta, AR: aortic arch, DA: descending aorta) and the whole heart was segmented. Average global standardized uptake value means were derived by sum of the product of each slice area divided by the sum of those slice areas. Results were reported as target to background ratio (TBR). Results: There was a significant difference between the NaF uptake in the thoracic aorta of myeloma and HC groups [AA (myeloma = 1.82 ± 0.21, HC = 1.24 ± 0.02), AR (myeloma = 1.71 ± 0.19, HC = 1.28 ± 0.03) and DA (myeloma = 1.96 ± 0.28, HC = 1.38 ± 0.03); P-values < 0.001]. The difference in the whole heart NaF uptake between two groups was also significant (P < 0.001). Conclusions: We observed a higher uptake of NaF in the thoracic aorta and whole heart of myeloma patients in comparison to the matched control group.